The natural product taiwaniaquinol B and the unnatural 5-epi-taiwaniaquinone G were synthesized based on a highly efficient tandem acylation-Nazarov cyclization approach to build the tricyclic skeleton.
The taiwaniaquinoids are a family of tricyclic diterpenoids possessing a [6, 5, 6 ]-abeo-abietane skeleton isolated from Taiwania cryptomerioides, Salvia dichroantha, Thuja standishii and other related plants [1] . The unusual structural features and the promising biological activities [1d,2] of these compounds have attracted great interest for their chemical synthesis [3, 4] .
The tandem acylation-Nazarov cyclization approach for the construction of fused cyclopentenones by treatment of aromatics with α,β-unsaturated carboxylic acids in the presence of TFAA and a suitable Lewis acid catalyst [5] has been proved highly efficient in natural product synthesis [5b,6] . Herein, we report our synthetic route towards taiwaniaquinol B and the unnatural 5-epi-taiwaniaquinone G using this strategy as a key step.
As shown in Scheme 1, treatment of resorcinol dimethyl ether (1) with β-cyclogeranic acid (2) in the presence of TFAA and ZnCl 2 resulted in the formation of the desired acylation-Nazarov cyclization product 3 in 57% isolated yield [6b]. The relative stereochemistry of 3 was assigned as cis on the basis of NOE correlations which was the thermodynamically more stable product. Selective deprotection of the methoxy group adjacent to the carbonyl group in 3 by treatment with BBr 3 gave 4, which was converted into hexahydrofluorene derivative 6 in excellent yield via hydrogenation of the intermediate tetrahydrofluorene 5. It needs to be indicated that all attempts to transform 4 directly into 6 via Wolff-Kishner or Clemmensen reduction failed to deliver the latter in any respectable yield. Next, the requisite isopropyl group was installed through a three-step sequence including Pechmann condensation of 6 with ethyl acetoacetate (EAA) to provide coumarin derivative 7, hydrolysis and hydrogenation, which led to the formation of 9 in excellent combined yield. Oxidation of 9 with CrO 3 gave 5-epi-taiwaniaquinone G 10, the spectroscopic data of which were identical to those previously reported in the literature [4c] . On the other hand, protection of the phenolic hydroxyl group in 9 gave 11, which on treatment with CrO 3 was oxidized to tetrahydrofluorenone 12. Finally, compound 12 could be converted into taiwaniaquinol B 13 following known literature procedures through selective demethylation, CAN oxidation, and sodium dithionite reduction [7] .
In summary, we have developed a facile route to the synthesis of taiwaniaquinol B and the unnatural 5-epi-taiwaniaquinone G. The key steps involve a tandem acylation-Nazarov cyclization reaction to build the tricyclic skeleton and a Pechmann condensation strategy to install the isopropyl group onto the aromatic ring.
Experimental
General: MP, XT4A hot-stage apparatus; IR, IFS25 FT-IR spectrometer; NMR, Agilent 400 MHz spectrometer; MS, Q-TOF micro spectrometer. Flash column chromatography was performed over silica gel 200-300 mesh. 6,7,8,8a,9-Hexahydro-2-isopropyl-3-methoxy-4b,8,8- 2.38 mmol) and 3,5-dimethylpyrazole (229 mg, 2.38 mmol) in DCM (6 mL) was stirred at -15ºC for 10 min. A solution of 9 (40 mg, 0.13 mmol) in DCM (6 mL) was added. The reaction mixture was allowed to warm to -10ºC and stirred for a further 1 h before being quenched with H 2 O (10 mL). The separated aqueous phase was extracted with DCM (3 x 10 mL). The combined organic extracts were dried over Na 2 SO 4 , then filtered and evaporated in vacuo. The residue was purified by column chromatography (CC) on silica gel (3% ethyl acetate in light petroleum) to give 5-epitaiwaniaquinone G 10 (38 mg, 90%) 5, 182.8, 156.7, 152.6, 146.3, 136.9, 61.2, 55.1, 48.1, 35.1, 34.4, 31.9, 31.2, 31.1, 29.6, 24.6, 24.4, 20.8, 20.7, 18. 2,3,4,4a,9,9a-Hexahydro-7-isopropyl-6,8-dimethoxy-1,1,4a trimethyl-1H-fluorene (11): Methyl iodide (68 µL, 1.1 mmol) was added dropwise to a mixture of 9 (58 mg, 0.19 mmol) and K 2 CO 3 (67 mg, 0.48 mmol) in acetone (3 mL) . After addition, the mixture was heated at reflux for 3 h, then cooled and evaporated in vacuo. 4, 155.0, 154.1, 126.4, 124.7, 101.1, 60.6, 57.6, 55.9, 45.6, 36.4, 35.3, 32.3, 31.2, 30.8, 29.6, 25.6, 25.1, 21.6, 21.5, 19. 2,3,4,4a-Tetrahydro-7-isopyopyl-6,8-dimethoxy-1,1,4a-trimethyl  -1H-fluoren-9(9aH)-one (12) [7] : A mixture of CrO 3 (326 mg, 3.27 mmol) and 3,5-dimethylpyrazole (317 mg, 3.27 mmol) in DCM (7 mL) was stirred at -15ºC for 10 min. A solution of 11 (58 mg, 0.18 mmol) in DCM (7 mL) was added. The reaction mixture was allowed to warm to -10ºC and stirred for 10 h before being quenched with H 2 O (15 mL). The separated aqueous phase was extracted with DCM (3 x 10 mL). The combined organic extracts were dried over Na 2 SO 4 , then filtered and evaporated in vacuo. The residue was purified by preparative TLC (3% ethyl acetate in light petroleum) to give 12 (21 mg, 46%, 71% based on recovered starting material) as a yellow oil, together with 20 mg of unreacted starting material recovered. MP: 136-137ºC. 1 H NMR (400 MHz, CDCl 3 ): 6.57 (s, 1H), 3.91 (s, 3H), 3.90 (s, 3H), 3.57 (sept, 1H, J =7.1 Hz), 2.11 (s, 1H), 2.07 (m, 1H), 1.65-1.56 (m, 2H), 1.51-1.32 (m, 3H), 1.28 (d, 6H, J = 7.1 Hz), 1.25 (s, 3H), 1.23 (s, 3H), 0.70 (s, 3H). 13 C NMR (100 MHz, CDCl 3 ): 204.5, 164.8, 164.0, 157.1, 128.1, 121.7, 99.8, 65.7, 62.1, 55.8, 41.4, 38.6, 34.5, 34.0, 33.4, 32.6, 24.7, 24.5, 21.2, 18.4. 
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